Jérôme Becquart
Vorstandsvorsitzender bei BrainVectis SAS
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yves Audebert | M | 67 |
Axiad IDS, Inc.
 Axiad IDS, Inc. Packaged SoftwareTechnology Services Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010. | 14 Jahre |
| Bassam Al-Khalidi | M | - |
Axiad IDS, Inc.
Axiad IDS, Inc. Packaged SoftwareTechnology Services Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010. | 14 Jahre |
| Nathalie Cartier-Lacave | M | - |
BrainVectis SAS
 BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | 9 Jahre |
| Dominique Fedronic | M | 61 |
GlobalPlatform, Inc.
 GlobalPlatform, Inc. Packaged SoftwareTechnology Services GlobalPlatform, Inc. is a technical standards organization that provides standardized technologies and certifications to empower technology and service providers to develop, certify, deploy, and manage digital services and devices in line with their business, security, regulatory and data protection needs. The non-profit company is based in Redwood City, CA. Its platform technologies are used in billions of smart cards, smartphones, wearables and other connected IoT devices. The company achieves end-to-end security, privacy, simplicity, and convenience to users by enabling the efficient launch and management of innovative, secure-by-design digital services and devices. The company's standardized technologies and certifications are developed through effective industry-driven collaboration, led by multiple diverse member companies working in partnership with industry and regulatory bodies and other interested parties from around the world. | 17 Jahre |
| David Canellos | M | 58 |
Axiad IDS, Inc.
Axiad IDS, Inc. Packaged SoftwareTechnology Services Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010. | - |
| John DeLoche | M | - |
Axiad IDS, Inc.
Axiad IDS, Inc. Packaged SoftwareTechnology Services Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010. | 3 Jahre |
| William Nettles | M | 51 |
Axiad IDS, Inc.
Axiad IDS, Inc. Packaged SoftwareTechnology Services Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010. | 3 Jahre |
| Benedikt Timmerman | M | 65 |
BrainVectis SAS
BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | - |
| Kevin Gillick | M | - |
GlobalPlatform, Inc.
GlobalPlatform, Inc. Packaged SoftwareTechnology Services GlobalPlatform, Inc. is a technical standards organization that provides standardized technologies and certifications to empower technology and service providers to develop, certify, deploy, and manage digital services and devices in line with their business, security, regulatory and data protection needs. The non-profit company is based in Redwood City, CA. Its platform technologies are used in billions of smart cards, smartphones, wearables and other connected IoT devices. The company achieves end-to-end security, privacy, simplicity, and convenience to users by enabling the efficient launch and management of innovative, secure-by-design digital services and devices. The company's standardized technologies and certifications are developed through effective industry-driven collaboration, led by multiple diverse member companies working in partnership with industry and regulatory bodies and other interested parties from around the world. | - |
| David Kennedy | M | - |
Axiad IDS, Inc.
Axiad IDS, Inc. Packaged SoftwareTechnology Services Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010. | 1 Jahre |
| Karen Larson | F | - |
Axiad IDS, Inc.
Axiad IDS, Inc. Packaged SoftwareTechnology Services Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Serge Timsit | M | - |
Neurokin SA
 Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | 11 Jahre |
| Bénédicte Menn | M | - |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | 11 Jahre |
| Yehezkel Ben-Ari | M | - |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | 11 Jahre |
| Régis Saleur | M | 56 |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | - |
| Bernard Reculeau | M | 72 |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | 4 Jahre |
| Célia Hart | M | - |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | - |
| Louis Jammayrac | M | - |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | - |
| Michel Kaczorek | M | - |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Frankreich | 10 | 52,63% |
| Vereinigte Staaten | 9 | 47,37% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jérôme Becquart
- Persönliches Netzwerk
